Wells Fargo says AbbVie is undervalued, sees biopharma stock rallying 36%

View Larger Image

Wells Fargo says AbbVie is undervalued, sees biopharma stock rallying 36%

AbbVie shares are down 9.7% in the past month.

By David Hilbern|2022-05-02T05:14:58-05:00May 2, 2022|Bankruptcy|0 Comments

About the Author: David Hilbern